E. Richards

发表

Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review

Allison C. Nugent, Carlos A. Zarate, E. Ballard, 2015, Therapeutic advances in chronic disease.

Therapeutic Modulation of Glutamate Receptors in Major Depressive Disorder

E. Ballard, A. Nugent, C. Zarate, 2016, Current neuropharmacology.

The role of adipokines in the rapid antidepressant effects of ketamine

E. Ballard, D. Luckenbaugh, C. Zarate, 2017, Molecular Psychiatry.

Reliability of 7T 1H‐MRS measured human prefrontal cortex glutamate, glutamine, and glutathione signals using an adapted echo time optimized PRESS sequence: A between‐ and within‐sessions investigation

Li An, Jun Shen, Níall Lally, 2016, Journal of magnetic resonance imaging : JMRI.

Preliminary evidence that early reduction in p11 levels in Natural Killer cells and monocytes predicts the likelihood of antidepressant response to chronic citalopram

P. Greengard, P. Svenningsson, C. Zarate, 2014, Molecular Psychiatry.

Building a database for brain 18 kDa translocator protein imaged using [11C]PBR28 in healthy subjects

R. Gunn, P. Zanotti-Fregonara, S. Zoghbi, 2019, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

PET radioligand binding to translocator protein (TSPO) is increased in unmedicated depressed subjects

W. Drevets, E. Ballard, P. Zanotti-Fregonara, 2018, EJNMMI Research.

Baseline working memory activation deficits in dimensional anxious depression as detected by magnetoencephalography

M. Furey, D. Luckenbaugh, A. Nugent, 2015, Acta Neuropsychiatrica.

Second messenger/signal transduction pathways in major mood disorders: moving from membrane to mechanism of action, part II: bipolar disorder

D. Ionescu, C. Zarate, M. Niciu, 2013, CNS Spectrums.

Acute Stress Symptoms Do Not Worsen in Posttraumatic Stress Disorder and Abuse with a Single Subanesthetic Dose of Ketamine

D. Luckenbaugh, D. Ionescu, C. Zarate, 2013, Biological Psychiatry.

Lithium and Valproate Levels Do Not Correlate with Ketamine's Antidepressant Efficacy in Treatment-Resistant Bipolar Depression

E. Ballard, D. Luckenbaugh, D. Ionescu, 2015, Neural plasticity.

Nocturnal Wakefulness is Associated with Next-Day Suicidal Ideation in Major Depression and Bipolar Disorder associated with next-day suicidal thoughts. PSG-documented sleep disruption at

E. Ballard, C. Zarate, M. Niciu, 2016 .

Anhedonia as a clinical correlate of suicidal thoughts in clinical ketamine trials.

E. Ballard, D. Luckenbaugh, C. Zarate, 2017, Journal of affective disorders.

Second messenger/signal transduction pathways in major mood disorders: moving from membrane to mechanism of action, part I: major depressive disorder

D. Ionescu, C. Zarate, M. Niciu, 2013, CNS Spectrums.

Antisuicidal Response Following Ketamine Infusion Is Associated With Decreased Nighttime Wakefulness in Major Depressive Disorder and Bipolar Disorder.

E. Ballard, D. Luckenbaugh, C. Zarate, 2017, The Journal of clinical psychiatry.

Nocturnal Wakefulness Is Associated With Next-Day Suicidal Ideation in Major Depressive Disorder and Bipolar Disorder.

M. Furey, E. Ballard, D. Luckenbaugh, 2016, The Journal of clinical psychiatry.

Improvement in suicidal ideation after ketamine infusion: relationship to reductions in depression and anxiety.

M. Furey, E. Ballard, D. Luckenbaugh, 2014, Journal of psychiatric research.

Ketamine’s Antidepressant Efficacy is Extended for at Least Four Weeks in Subjects with a Family History of an Alcohol Use Disorder

M. Furey, E. Ballard, D. Luckenbaugh, 2014, The international journal of neuropsychopharmacology.

Multiple levels of impaired neural plasticity and cellular resilience in bipolar disorder: Developing treatments using an integrated translational approach

C. Zarate, R. Machado-Vieira, E. Richards, 2014, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

A single infusion of ketamine improves depression scores in patients with anxious bipolar depression.

D. Luckenbaugh, D. Ionescu, C. Zarate, 2015, Bipolar disorders.

Experimental Pharmacologic Approaches for the Reduction of Suicidal Ideation and Behavior

E. Ballard, D. Ionescu, C. Zarate, 2014 .

Do the dissociative side effects of ketamine mediate its antidepressant effects?

D. Luckenbaugh, D. Ionescu, C. Zarate, 2014, Journal of affective disorders.

Glutamate and its receptors in the pathophysiology and treatment of major depressive disorder

D. Ionescu, C. Zarate, M. Niciu, 2014, Journal of Neural Transmission.

A randomized, placebo-controlled pilot trial of the delta opioid receptor agonist AZD2327 in anxious depression

D. Luckenbaugh, D. Ionescu, C. Zarate, 2016, Psychopharmacology.

DEVELOPING BIOMARKERS IN MOOD DISORDERS RESEARCH THROUGH THE USE OF RAPID‐ACTING ANTIDEPRESSANTS

M. Furey, A. Nugent, D. Ionescu, 2014, Depression and anxiety.

Biomarkers in mood disorders research: developing new and improved therapeutics.

M. Furey, A. Nugent, D. Ionescu, 2014, Revista de psiquiatria clinica.

Neurobiological aspects of suicide and suicide attempts in bipolar disorder

D. Ionescu, C. Zarate, M. Niciu, 2013, Translational neuroscience.

cAMP Signaling in Brain is Decreased in Unmedicated Depressed Patients and Increased by Treatment with a Selective Serotonin Reuptake Inhibitor

Robert B. Innis, Victor W. Pike, Sami S. Zoghbi, 2016, Molecular Psychiatry.

Baseline Vitamin B12 and Folate Levels Do Not Predict Improvement in Depression After a Single Infusion of Ketamine

D. Luckenbaugh, D. Ionescu, C. Zarate, 2014, Pharmacopsychiatry.

NEUROBIOLOGY OF ANXIOUS DEPRESSION: A REVIEW

D. Ionescu, C. Zarate, M. Niciu, 2013, Depression and anxiety.

The management of mood disorders in pregnancy: alternatives to antidepressants

J. Payne, E. Richards, 2013, CNS Spectrums.

Characterizing the course of suicidal ideation response to ketamine.

E. Ballard, C. Zarate, M. Niciu, 2018, Journal of affective disorders.

Assessing measures of suicidal ideation in clinical trials with a rapid-acting antidepressant.

E. Ballard, D. Luckenbaugh, C. Zarate, 2015, Journal of psychiatric research.

Clinical predictors of ketamine response in treatment-resistant major depression.

D. Luckenbaugh, D. Ionescu, C. Zarate, 2014, The Journal of clinical psychiatry.

Riluzole likely lacks antidepressant efficacy in ketamine non-responders.

M. Furey, E. Ballard, D. Luckenbaugh, 2014, Journal of psychiatric research.

Pharmacologic treatment of dimensional anxious depression: a review.

D. Ionescu, C. Zarate, M. Niciu, 2014, The primary care companion for CNS disorders.

Effect of baseline anxious depression on initial and sustained antidepressant response to ketamine.